Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy (2010)
- Autor:
- Autor USP: SILVA, DENISE DE OLIVEIRA - IQ
- Unidade: IQ
- Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES; COMPOSTOS DE COORDENAÇÃO; ANTINEOPLÁSICOS (ATIVIDADE)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Anti-Cancer Agents in Medicinal Chemistry
- ISSN: 1871-5206
- Volume/Número/Paginação/Ano: v. 10, n. 4, p. 312-323, 2010
-
ABNT
SILVA, Denise de Oliveira. Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy. Anti-Cancer Agents in Medicinal Chemistry, v. 10, n. 4, p. 312-323, 2010Tradução . . Disponível em: http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/58312628.1/ben/acamc/2010/00000010/00000004/art00006/F0AEB97433A916471282681475F9886F0D732F7F53.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf. Acesso em: 05 maio 2024. -
APA
Silva, D. de O. (2010). Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy. Anti-Cancer Agents in Medicinal Chemistry, 10( 4), 312-323. Recuperado de http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/58312628.1/ben/acamc/2010/00000010/00000004/art00006/F0AEB97433A916471282681475F9886F0D732F7F53.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf -
NLM
Silva D de O. Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2010 ; 10( 4): 312-323.[citado 2024 maio 05 ] Available from: http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/58312628.1/ben/acamc/2010/00000010/00000004/art00006/F0AEB97433A916471282681475F9886F0D732F7F53.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf -
Vancouver
Silva D de O. Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2010 ; 10( 4): 312-323.[citado 2024 maio 05 ] Available from: http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/58312628.1/ben/acamc/2010/00000010/00000004/art00006/F0AEB97433A916471282681475F9886F0D732F7F53.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf - Estudo da influência de condições sintéticas na composição de complexos mistos de rutênio-DMSO-(ligante piridinico) preparados a partir de [Ru'Cl IND.2''(DMSO) IND.4']
- Estudo da reatividade do complexo tetra-`mü´-(ibuprofenato) clorodirutênio(II,III)
- Sintese e estrutura cristalina de dois novos tetracarboxilatos de dimolibidenio
- Synthesis and characterization of metal-metal bonded diruthenium(II,III)-dicarboxylate microporous compounds
- Síntese, caracterização e atividade biológica dos complexos ['M IND.2''('mü'-'O IND. 2'CC'H IND. 3) IND. 4''(nimorazol) IND. 2']X (M = Ru e X = 'PF IND. 6'; M = Rh)
- Synthesis and characterization of a diruthenium complex with the drug sulindac
- A Ru(II)-p-cymene compound bearing naproxen-pyridineamide. Synthesis, spectroscopic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands
- Combined copper-naproxen drug/crosslinked chitosan-glutaraldeyde microspheres
- Novel diruthenium-sulindac and diruthenium-diclofenac metallodrugs and the antitumor activity against K562 cells
- Preparation and Characterization of Crosslinked Chitosan Microspheres Impregnated with the Drug Ketoprofen
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
